A Phase II Trial of Rechallenge With Panitumumab Driven by RAS Clonal-mediated Dynamic of Resistance
Phase of Trial: Phase II
Latest Information Update: 21 Nov 2017
At a glance
- Drugs Panitumumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms CHRONOS
- 31 Aug 2018 Biomarkers information updated
- 15 Nov 2017 Status changed from not yet recruiting to recruiting.
- 06 Sep 2017 Planned initiation date changed from 1 Jul 2017 to 1 Oct 2017.